Startup Funding Tracker

Fitholic funding, investors and company details

Fitholic is an emerging Healthcare - Nutrition startup from New Delhi, working in the space of Health-tech and nutrition company operating at the intersection of diagnostics and dietary supplements, with a focus on transparency, preventive care, and high-quality nutrition. Founded by Manish Harinand Kaushik.

  • Company: Fitholic Gym Private Limited
  • Sector: Healthcare - Nutrition
  • Location: New Delhi
  • Founders: Manish Harinand Kaushik
  • Total funding raised: ₹32.7 Cr

Company overview

Fitholic is an India-based health-tech and nutrition company operating at the intersection of diagnostics and dietary supplements, with a focus on transparency, preventive care, and high-quality nutrition. The company has rapidly emerged as a credible name in the wellness ecosystem. The business initially started as a diagnostics service provider, offering home sample collection, AI-enabled health insights, and digitally accessible smart reports. By collaborating exclusively with NABL-accredited and CAP-USA standard laboratories, Fitholic prioritizes accuracy and reliability in testing for vitamins, minerals, and other key health markers—addressing the common challenge of inconsistent diagnostic quality in India. Building on its diagnostics foundation, Fitholic has expanded into the direct-to-consumer (D2C) nutrition segment with a range of dietary supplements aimed at making India more “nutrition efficient.” The company seeks to deliver high-quality nutritional products through a convenient and seamless customer experience, aligned with the rising demand for preventive health and wellness solutions. At its core, Fitholic promotes a prevention-first philosophy, encouraging individuals to regularly track their health and nutritional status rather than responding only after illness occurs. This approach reflects its broader objective of transforming how Indians engage with diagnostics and nutrition. Fitholic’s guiding principles—accuracy, transparency, and trust—are reflected in its accredited lab partnerships, doorstep convenience, and digital accessibility, ensuring that every test and product empowers consumers to make informed, proactive health decisions.

Funding rounds

  • Latest round (Pre-Seed): $ 4.00 Mn (₹32.70 Cr.), 2023-01-19